Impulse Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 5.00 Cr
as on 23-10-2024
- Company Age 22 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.00 Cr
as on 23-10-2024
- Satisfied Charges ₹ 25.71 Cr
as on 23-10-2024
- Revenue -5.90%
(FY 2023)
- Profit 12.70%
(FY 2023)
- Ebitda 8.47%
(FY 2023)
- Net Worth 18.23%
(FY 2023)
- Total Assets 46.90%
(FY 2023)
About Impulse Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹20.00 Cr. The company has closed loans amounting to ₹25.71 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Patil, Swapnil Patil, Digambar Zawar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24230MH2002PTC137705
- Company No.
137705
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Oct 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Impulse Pharma Private Limited offer?
Impulse Pharma Private Limited offers a wide range of products and services, including Paracetamol Tablets, Combiflam Tablet, Pain Reliever Gel, Combiflam Gel, Pain Relief Spray, Combiflam Pain Relief Spray.
Who are the key members and board of directors at Impulse Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Zawar  | Managing Director | 28-Apr-2016 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Patil | Director | 23-Mar-2010 | Current |
| Swapnil Patil | Director | 23-Mar-2010 | Current |
| Digambar Zawar | Director | 28-Oct-2002 | Current |
| Pushkar Zawar | Director | 28-Mar-2023 | Current |
| Niraj Zawar | Director | 22-Feb-2023 | Current |
Financial Performance and Corporate Structure Insights of Impulse Pharma.
Impulse Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.9% decrease. The company also saw a substantial improvement in profitability, with a 12.7% increase in profit. The company's net worth Soared by an impressive increase of 18.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Impulse Pharma?
In 2023, Impulse Pharma had a promoter holding of 87.40% and a public holding of 12.60%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kamla Lifesciences LimitedActive 12 years 8 monthsDigambar Zawar and Rajendra Zawar are mutual person
- Kamford Healthcare Private LimitedActive 5 years 2 months
Digambar Zawar and Rajendra Zawar are mutual person
- Kitemed Healthcare Private LimitedActive 2 years 7 months
Digambar Zawar and Rajendra Zawar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Jul 2021 | ₹20.00 Cr | Open |
Axis Bank Limited Creation Date: 12 Sep 2017 | ₹5.00 Cr | Satisfied |
Others Creation Date: 20 Mar 2013 | ₹11.95 Cr | Satisfied |
How Many Employees Work at Impulse Pharma?
Impulse Pharma has a workforce of 100 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Impulse Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Impulse Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
